131 related articles for article (PubMed ID: 18406703)
1. Is brain tumor recurrence increased following growth hormone treatment?
Moshang T
Trends Endocrinol Metab; 1995 Aug; 6(6):205-9. PubMed ID: 18406703
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone deficiency following radiation therapy of primary brain tumors in children.
Kanev PM; Lefebvre JF; Mauseth RS; Berger MS
J Neurosurg; 1991 May; 74(5):743-8. PubMed ID: 2013774
[TBL] [Abstract][Full Text] [Related]
3. Growth failure after treatment of pediatric brain tumors.
Clarson CL; Del Maestro RF
Pediatrics; 1999 Mar; 103(3):E37. PubMed ID: 10049993
[TBL] [Abstract][Full Text] [Related]
4. Tumour occurrence and recurrence.
Ogilvy-Stuart AL; Shalet SM
Horm Res; 1992; 38 Suppl 1():50-5. PubMed ID: 1295813
[TBL] [Abstract][Full Text] [Related]
5. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
Whitman BY; Myers S; Carrel A; Allen D
Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone treatment of children with brain tumors and risk of tumor recurrence.
Swerdlow AJ; Reddingius RE; Higgins CD; Spoudeas HA; Phipps K; Qiao Z; Ryder WD; Brada M; Hayward RD; Brook CG; Hindmarsh PC; Shalet SM
J Clin Endocrinol Metab; 2000 Dec; 85(12):4444-9. PubMed ID: 11134091
[TBL] [Abstract][Full Text] [Related]
7. Brain tumor recurrence in children treated with growth hormone: the National Cooperative Growth Study experience.
Moshang T; Rundle AC; Graves DA; Nickas J; Johanson A; Meadows A
J Pediatr; 1996 May; 128(5 Pt 2):S4-7. PubMed ID: 8627468
[TBL] [Abstract][Full Text] [Related]
8. The growth hormone cascade: progress and long-term results of growth hormone treatment in growth hormone deficiency.
Grumbach MM; Bin-Abbas BS; Kaplan SL
Horm Res; 1998; 49 Suppl 2():41-57. PubMed ID: 9730672
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone therapy and tumor recurrence. Findings in children with brain neoplasms and hypopituitarism.
Arslanian SA; Becker DJ; Lee PA; Drash AL; Foley TP
Am J Dis Child; 1985 Apr; 139(4):347-50. PubMed ID: 3976624
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone treatment and risk of recurrence or development of secondary neoplasms in survivors of pediatric brain tumors.
Wang ZF; Chen HL
J Clin Neurosci; 2014 Dec; 21(12):2155-9. PubMed ID: 25065848
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone therapy and malignancy.
Shalet SM; Brennan BM; Reddingius RE
Horm Res; 1997; 48 Suppl 4():29-32. PubMed ID: 9350443
[TBL] [Abstract][Full Text] [Related]
12. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
Ogilvy-Stuart AL; Stirling HF; Kelnar CJ; Savage MO; Dunger DB; Buckler JM; Shalet SM
Clin Endocrinol (Oxf); 1997 May; 46(5):571-8. PubMed ID: 9231053
[TBL] [Abstract][Full Text] [Related]
13. Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours.
Weinzimer SA; Homan SA; Ferry RJ; Moshang T
Clin Endocrinol (Oxf); 1999 Sep; 51(3):339-45. PubMed ID: 10469014
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
15. Melanocytic nevi in children treated with growth hormone.
Wyatt D
Pediatrics; 1999 Oct; 104(4 Pt 2):1045-50. PubMed ID: 10506263
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone treatment and cancer risk.
Banerjee I; Clayton PE
Endocrinol Metab Clin North Am; 2007 Mar; 36(1):247-63. PubMed ID: 17336744
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone release in children after cranial irradiation.
Lannering B; Albertsson-Wikland K
Horm Res; 1987; 27(1):13-22. PubMed ID: 3114116
[TBL] [Abstract][Full Text] [Related]
18. Clinical and reimbursement issues in growth hormone use in adults.
Biller BM; Vance ML; Kleinberg DL; Cook DM; Gordon T
Am J Manag Care; 2000 Sep; 6(15 Suppl):S817-27. PubMed ID: 11184423
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone in the brain: characteristics of specific brain targets for the hormone and their functional significance.
Nyberg F
Front Neuroendocrinol; 2000 Oct; 21(4):330-48. PubMed ID: 11013068
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of sellar and suprasellar tumors in children treated with hGH--relation to immunohistochemical study on GH receptor.
Uchino Y; Saeki N; Iwadate Y; Yasuda T; Konda S; Watanabe T; Wada K; Kazukawa I; Higuchi Y; Iuchi T; Tatsuno I; Yamaura A
Endocr J; 2000 Mar; 47 Suppl():S33-6. PubMed ID: 10890179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
